Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

17 Mar 2018
Nonvitamin K antagonist oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) and vitamin K antagonists-ICH appear to have similar ICH volume, haematoma expansion, functional outcome and mortality, results of a recent meta-analysis have shown.
31 May 2017
New drug applications approved by US FDA as of 16 - 31 May 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
09 Dec 2017
Intravenous (IV) iron is less toxic and more effective compared to oral iron, making it a potential frontline therapy for neonatal iron deficiency anaemia, suggests a recent study.

Unnecessary antibiotics for asthma linked to longer hospital stay, elevated cost

Roshini Claire Anthony
07 Jun 2018

Prescribing antibiotics despite no indication of infection to patients hospitalized with asthma was associated with longer hospital stay, a higher risk of antibiotic-related diarrhoea, and elevated hospitalization costs, according to a study presented at the recent American Thoracic Society conference (ATS 2018).

“Our results strengthen the evidence that antibiotics should not be prescribed routinely in adult patients hospitalized with asthma,” said study lead author Associate Professor Mihaela S. Stefan from the University of Massachusetts Medical School, Springfield, Massachusetts, US.

In this retrospective cohort study, Stefan and co-authors assessed data of 22,043 adult patients (aged >18 years) admitted to 554 acute care hospitals in the US for asthma exacerbation between January 2015 and December 2016. Patients had to be receiving systemic corticosteroids to be included in the study, while patients who required antibiotics for other indications (eg, sinus infection, bronchitis, pneumonia, emphysema, sepsis) were excluded.

Of the cohort, 46.1 percent received antibiotics for ≥2 days initiated within the first 2 days of hospitalization. Compared with those who did not receive antibiotics, the patients who did tended to be older (mean age, 50.5 vs 46.6 years), Caucasian (49.6 percent vs 41.5 percent), and smokers (7.6 percent vs 5.5 percent).

Length of hospitalization appeared to be longer in patients who received antibiotics compared with those who did not (mean, 4.4 vs 3.4 days; p<0.0001). [ATS 2018, abstract 16204]

Compared with patients who did not receive antibiotics, those who did also incurred higher hospitalization costs (mean, US$ 6,427 vs 5,387) and had an elevated risk of experiencing antibiotic-related diarrhoea (odds ratio [OR], 1.55, 95 percent confidence interval [CI], 1.16–2.08).

Risk of treatment failure, defined as invasive or noninvasive mechanical ventilation, admission to the intensive care unit after 2 days of hospitalization, in-hospital mortality, or readmission to hospital due to asthma exacerbation within 30 days of discharge, was comparable between patients who did and did not receive antibiotics (5.56 percent vs 5.64 percent, OR, 1.02, 95 percent CI, 0.88–1.17).

“Clinical guidelines, including the Global Initiative for Asthma, state that there is no role for antibiotics in asthma exacerbations unless there is strong evidence of lung infection,” said Stefan.

“[However], more than half of patients hospitalized for asthma receive antibiotics in the absence of a clear indication [though] few studies have assessed whether antibiotics could be beneficial in these patients,” she said.

“All hospitals should assess their practice in caring for patients hospitalized with asthma and increase their antibiotic stewardship,” suggested Stefan.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

17 Mar 2018
Nonvitamin K antagonist oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) and vitamin K antagonists-ICH appear to have similar ICH volume, haematoma expansion, functional outcome and mortality, results of a recent meta-analysis have shown.
31 May 2017
New drug applications approved by US FDA as of 16 - 31 May 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
09 Dec 2017
Intravenous (IV) iron is less toxic and more effective compared to oral iron, making it a potential frontline therapy for neonatal iron deficiency anaemia, suggests a recent study.